Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahboubeh Yazdanifar

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Critical Reviews in Microbiology|October 7, 2020
Making a case for using γδ T cells against SARS-CoV-2Mahboubeh Yazdanifar, Narges Mashkour, Alice Bertaina
Current Trends in Immunology|June 30, 2017
Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cellsMahboubeh Yazdanifar, Ru Zhou, Pinku Mukherjee
Frontiers in Immunology|June 28, 2021
Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A ReviewPriscila Ferreira Slepicka, Mahboubeh Yazdanifar, Alice Bertaina
Cells|May 28, 2020
γδ T Cells: The Ideal Tool for Cancer ImmunotherapyMahboubeh Yazdanifar, Giulia Barbarito, Alice Bertaina, et al.
Cells|July 26, 2020
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK CellsFabio Morandi, Mahboubeh Yazdanifar, Claudia Cocco, et al.
Pharmaceutical Research|June 11, 2021
Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf ProductsMuhammad Sadeqi Nezhad, Meghdad Abdollahpour-Alitappeh, Behzad Rezaei, et al.
Cancer Cell International|June 8, 2021
Overcoming the UCB HSCs -Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling PathwaysAlireza Shokouhifar, Gholamreza Anani Sarab, Mahboubeh Yazdanifar, et al.
Biotechnology and Bioengineering|July 9, 2021
Strengthening the CAR-T cell therapeutic application using CRISPR/Cas9 technologyMuhammad Sadeqi Nezhad, Mahboubeh Yazdanifar, Meghdad Abdollahpour-Alitappeh, et al.
Expert Review of Clinical Immunology|September 26, 2022
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectivesPooya Farhangnia, Mahzad Akbarpour, Mahboubeh Yazdanifar, et al.
Frontiers in Immunology|June 11, 2019
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Critical Reviews in Microbiology|October 7, 2020
Making a case for using γδ T cells against SARS-CoV-2Mahboubeh Yazdanifar, Narges Mashkour, Alice Bertaina
Current Trends in Immunology|June 30, 2017
Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cellsMahboubeh Yazdanifar, Ru Zhou, Pinku Mukherjee
Frontiers in Immunology|June 28, 2021
Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A ReviewPriscila Ferreira Slepicka, Mahboubeh Yazdanifar, Alice Bertaina
Cells|May 28, 2020
γδ T Cells: The Ideal Tool for Cancer ImmunotherapyMahboubeh Yazdanifar, Giulia Barbarito, Alice Bertaina, et al.
Cells|July 26, 2020
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK CellsFabio Morandi, Mahboubeh Yazdanifar, Claudia Cocco, et al.
Pharmaceutical Research|June 11, 2021
Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf ProductsMuhammad Sadeqi Nezhad, Meghdad Abdollahpour-Alitappeh, Behzad Rezaei, et al.
Cancer Cell International|June 8, 2021
Overcoming the UCB HSCs -Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling PathwaysAlireza Shokouhifar, Gholamreza Anani Sarab, Mahboubeh Yazdanifar, et al.
Biotechnology and Bioengineering|July 9, 2021
Strengthening the CAR-T cell therapeutic application using CRISPR/Cas9 technologyMuhammad Sadeqi Nezhad, Mahboubeh Yazdanifar, Meghdad Abdollahpour-Alitappeh, et al.
Expert Review of Clinical Immunology|September 26, 2022
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectivesPooya Farhangnia, Mahzad Akbarpour, Mahboubeh Yazdanifar, et al.
Frontiers in Immunology|June 11, 2019
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer GrowthRu Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, et al.
Pageof 3